Skip to main content

Mediation for Helicos Suit Against PacBio, Life Tech, and Illumina Rescheduled for Early 2012

Premium

Mediation conferences to potentially resolve Helicos BioSciences' patent lawsuit against Pacific Biosciences, Life Technologies, and Illumina have been rescheduled for early 2012, according to a court order filed this week.

Originally, the conferences had been scheduled for late August of this year but were canceled due to a hurricane on the East Coast (IS 7/26/2011 and IS 9/13/2011).

Helicos is now scheduled to meet with PacBio on Jan. 17 or 18, or on April 24, 2012, depending on the court's availability; with Illumina on Feb. 13; and with Life Tech on Feb. 14.

Helicos first filed the suit against PacBio in late 2010 in the US District Court for the District of Delaware, claiming that PacBio's sequencing technology infringes four of its patents, and later added Illumina and Life Tech as defendants to the suit.

PacBio, Illumina, and Life Tech later countersued Helicos, claiming that several of the patents are invalid and unenforceable.

Separately, the United States Patent and Trademark Office initiated the reexamination of several Helicos patents, including those under dispute, following requests from PacBio and Life Tech (IS 9/13/2011).

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.